Search results for Consumer Healthcare Products Association (Chpa)

<![CDATA[Strengthening the Generic Drugs Supply Chain]]>

<![CDATA[The Industry’s Communication and Engagement with FDA]]>

<![CDATA[Global leader in engagement with healthcare stakeholders]]>

<![CDATA[Pharmaceutical Executive Daily: CVS Health to Offer Zepbound and Foundayo]]>

Senators Introduce Dietary Supplements Access Act, Industry Responds

On May 20, U.S. Senators Kevin Cramer (R-ND) and John Curtis (R-UT) introduced the Dietary Supplements Access Act, legislation that would allow dietary supplements to be purchased...

<![CDATA[FDA's Timeline for DTC Prescription Drug Ad Oversight]]>

<![CDATA[The Impact of Strict Oversight on DTC Prescription Drug Ads]]>

<![CDATA[How Compounding Has Become a Permanent Bridge for Healthcare Access: Q&A with Dr. Nicole Snow]]>

<![CDATA[Model Examples]]>

<![CDATA[A New Standard for Copay Excellence: Q&A with Brian Laird]]>

<![CDATA[The Push at FDA to Tighten Oversight on DTC Prescription Drug Ads]]>

Navigating evolving regulatory frameworks across markets

The nutraceutical industry has emerged as one of the fastest growing sectors within global healthcare driven by rising consumer demand for preventive wellness functional nutrition...

ALL EYES ON CMS: Federal Fight Could Decide Whether Unapproved Cannabinoids Reach America's Seniors

"MMJ International Holdings Rebuts Federal Claim of "No Standing" in CMS Hemp Litigation: "This Case Is About Protecting Medicare Patients and the FDA Drug Approval System" stated...

Industry group says health plans have cut 11% of prior authorizations

MMJ International Holdings Joins Federal Lawsuit on 4/20 to Stop CMS From Introducing Unvalidated Cannabinoid Products I...

"MMJ International Holdings Joins Smart Approaches to Marijuana et al, Federal Challenge to CMS Hemp Program on 4/20: "Botanical Therapies Must Meet FDA Standards-Not Political Tim...

<![CDATA[New Federal Market Access Restrictions: Optimizing Manufacturer Strategies as PBMs Gain Power]]>

<![CDATA[Pharmaceutical Executive Daily: AbbVie and Haisco Enter $745 Million Licensing Agreement]]>

Healthy Extracts' Gummy USA Secures Major U.S. Manufacturing Partnership with Imaraïs Beauty

Initial Production Order includes Initial Five SKUs for 4,800+ Premier Isle End-Cap Placements at a Leading National Retailer, Supporting Rapid Expansion in the $720 Billion Health...

<![CDATA[Haisco Enters $745 Million Exclusive License Agreement with AbbVie ]]>

<![CDATA[Pharmaceutical Executive: May 2026 Interactive Digital Edition]]>

Beyond Formulary Access: Building a Scalable Pharmaceutical Manufacturer Commercial Platform for Direct-to-Consumer and...

Today’s guest post comes from Laura Jensen, Chief Commercial Officer and President, Pharma Direct at GoodRx. Laura suggests that manufacturers must move beyond payer-centric model...

Bipartisan Push for FDA “Pre-Review” of DTC Drug Ads

By Charles D. Snow & Dara Katcher Levy —

<![CDATA[Maximizing Drug Impact]]>

<![CDATA[World Health Day 2026: Quotes that Stand with Science ]]>